1. EachPod

ReachMD CME - Podcast

ReachMD CME

 ReachMD

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Health Medicine Science & Medicine
Update frequency
every day
Episodes
499
Years Active
2019 - 2025
Share to:
Current Diagnostic Signs, Symptoms, and Lab Tests for FNAIT

Current Diagnostic Signs, Symptoms, and Lab Tests for FNAIT

CME credits: 1.00
Valid until: 31-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/current-diagnostic-signs-symptoms-and-lab-tests-for-fnait/32277/

Fetal and neonatal alloim…

Fri 31 Jan 2025
No Patient Left Behind! Advancing CKD-Associated Pruritus Care

No Patient Left Behind! Advancing CKD-Associated Pruritus Care

CME credits: 0.25
Valid until: 31-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/no-patient-left-behind-advancing-ckd-associated-pruritus-care/26637/

Patients with chronic…

Fri 31 Jan 2025
The Alloimmune Disorders of Pregnancy

The Alloimmune Disorders of Pregnancy

CME credits: 1.00
Valid until: 31-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/the-alloimmune-disorders-of-pregnancy/32274/

Fetal and neonatal alloimmune thrombocytopeni…

Fri 31 Jan 2025
Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): The Platelet Equivalent of Rh Disease

Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): The Platelet Equivalent of Rh Disease

Fri 31 Jan 2025
Neonatal FcRn Inhibition: A New Pathway for Addressing the Alloimmune Disorders of Pregnancy

Neonatal FcRn Inhibition: A New Pathway for Addressing the Alloimmune Disorders of Pregnancy

Fri 31 Jan 2025
Managing the “Next Pregnancy” in Patients With an FNAIT-Affected First Child

Managing the “Next Pregnancy” in Patients With an FNAIT-Affected First Child

CME credits: 1.00
Valid until: 31-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/managing-the-next-pregnancy-in-patients-with-an-fnait-affected-first-child/32279/

Fetal an…

Fri 31 Jan 2025
A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies

A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies

Sat 25 Jan 2025
Long-Term Safety of DMTs: What We Know and What We Need to Know

Long-Term Safety of DMTs: What We Know and What We Need to Know

CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/long-term-safety-of-dmts-what-we-know-and-what-we-need-to-know/32226/

This series of bite-…

Fri 24 Jan 2025
Preparing the Patient with Decompensated Cirrhosis for Liver Transplant: ICU Discussions, Considerations and Dialysis

Preparing the Patient with Decompensated Cirrhosis for Liver Transplant: ICU Discussions, Considerations and Dialysis

Fri 24 Jan 2025
Brain Health in MS: A Comprehensive Approach

Brain Health in MS: A Comprehensive Approach

CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/brain-health-in-ms-a-comprehensive-approach/32233/

This series of bite-sized episodes cont…

Fri 24 Jan 2025
Acute Kidney Injury in Cirrhosis: Multidisciplinary Decision-Making

Acute Kidney Injury in Cirrhosis: Multidisciplinary Decision-Making

CME credits: 0.50
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/acute-kidney-injury-in-cirrhosis-multidisciplinary-decision-making/26986/

In patients with…

Fri 24 Jan 2025
High-Efficacy DMTs: Transforming MS Care

High-Efficacy DMTs: Transforming MS Care

CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/high-efficacy-dmts-transforming-ms-care/32225/

This series of bite-sized episodes contains…

Fri 24 Jan 2025
Imaging Biomarkers: MS Progression in Focus

Imaging Biomarkers: MS Progression in Focus

CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/imaging-biomarkers-ms-progression-in-focus/32230/

This series of bite-sized episodes conta…

Fri 24 Jan 2025
Balancing Act: Immune Reconstitution vs. Immune Suppression

Balancing Act: Immune Reconstitution vs. Immune Suppression

CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/balancing-act-immune-reconstitution-vs-immune-suppression/32227/

This series of bite-sized…

Fri 24 Jan 2025
From Pathology to Practice: The Role of Inflammation in MS Pathology

From Pathology to Practice: The Role of Inflammation in MS Pathology

CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/from-pathology-to-practice-the-role-of-inflammation-in-ms-pathology/32228/

This series of …

Fri 24 Jan 2025
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care

Personalized Care for Diverse MS Populations: Special Populations Equal Special Care

Fri 24 Jan 2025
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies

MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies

CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/ms-cognitive-insights-management-diagnostic-and-treatment-strategies/32232/

This series of…

Fri 24 Jan 2025
Fluid Biomarkers: Revolutionizing MS Diagnosis

Fluid Biomarkers: Revolutionizing MS Diagnosis

CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/fluid-biomarkers-revolutionizing-ms-diagnosis/32229/

This series of bite-sized episodes co…

Fri 24 Jan 2025
PROs in MS: A New Era of Patient-Centric Care

PROs in MS: A New Era of Patient-Centric Care

CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/pros-in-ms-a-new-era-of-patient-centric-care/32234/

This series of bite-sized episodes con…

Fri 24 Jan 2025
Emerging data with potentially guideline-changing implications in CLL/SLL and MCL

Emerging data with potentially guideline-changing implications in CLL/SLL and MCL

Thu 23 Jan 2025
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.